ALKBH5 and pancreatic neoplasm: ALKBH5-mediated elevation of DNA-damage-inducible transcript 4 antisense RNA 1 (DDIT4-AS1) sustains pancreatic cancer stem-like properties and reduces chemotherapeutic responsiveness through mTOR pathway activation.